Title Identification and semisynthesis of(-)-anisomelic acid as oral agent against SARS-CoV-2 in mice
Authors Hai-Xin Yu
Nan Zheng
Chi-Tai Yeh
Chien-Ming Lee
Qi Zhang
Wen-Lv Zheng
Qing Chang
Yuan-He Li
Yu-Jun Li
Gui-Zhen Wu
Jun-Min Quan
Lin-Qi Zhang
Yew-Min Tzeng
Zhen Yang
Affiliation Laboratory of Chemical Genomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School
Department of Medicinal Research and Education,Taipei Medical University-Shuang Ho Hospital
Department of Applied Science, Taitung University
Center for Global Health and Infectious Diseases,Comprehensive AIDS Research Center, and Beijing Advanced Innovation Center for Structural Biology, School of Medicine, Tsinghua University
Lanzhou Institute of Separation Science
State Key Laboratory of Bioorganic Chemistry and Molecular Engineering of Ministry of Education and Beijing National Laboratory for Molecular Science(BNLMS), College of Chemistry and Molecular Engineering,Peking University
Shenzhen Bay Laboratory
NHC Key Laboratory of Biosafety,National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention
Department of Applied Chemistry,Chaoyang University of Technology
Keywords identification
enantioselective semisynthesis
(-)-anisomelic acid
oral agent
anti-SARS-CoV-2
Issue Date 30-Nov-2022
Publisher National Science Review
Abstract (-)-Anisomelic acid, isolated from Anisomeles indica(L.) Kuntze(Labiatae) leaves, is a macrocyclic cembranolide with a trans-fused α-methylene-γ-lactone motif. Anisomelic acid effectively inhibits SARS-Co V-2 replication and viral-induced cytopathic effects with an EC50 of 1.1 and 4.3 μM, respectively.Challenge studies of SARS-CoV-2-infected K18-hACE2 mice showed that oral administration of anisomelic acid and subcutaneous dosing of remdesivir can both reduce the viral titers in the lung tissue at the same level. To facilitate drug discovery, we used a semisynthetic approach to shorten the project timelines. The enantioselective semisynthesis of anisomelic acid from the naturally enriched and commercially available starting material(+)-costunolide was achieved in five steps with a 27% overall yield.The developed chemistry provides opportunities for developing anisomelic-acid-based novel ligands for selectively targeting proteins involved in viral infections.
URI http://hdl.handle.net/20.500.11897/667348
ISSN 2095-5138
Indexed 中国科学引文数据库(CSCD)
Appears in Collections: 化学生物学与生物技术学院
化学与分子工程学院
生物有机与分子工程教育部重点实验室

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

百度学术™


0

Checked on Current Time




License: See PKU IR operational policies.